HGF induces uveal melanoma cell proliferation and survival, which produces resistance to MET inhibitors, such as crizotinib and cabozantinib, in metastatic uveal melanoma tumors (Croce et al., 2019). This evidence concerns the gene MET and uveal melanoma.